Intuitive announces fda clearance of da vinci single port for transanal local excision/resection

Sunnyvale, calif., may 01, 2025 (globe newswire) -- intuitive (nasdaq: isrg), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the u.s. food and drug administration (fda) cleared the da vinci single port (sp) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. this clearance extends the da vinci sp's capabilities in colorectal surgery, building upon procedures previously cleared by the fda in november 2024, which include transabdominal procedures - low anterior resection, total mesorectal excision, colectomy, abdominoperineal resection, and sigmoidectomy.
ISRG Ratings Summary
ISRG Quant Ranking